Xxxx, Xxxxx X. Xxxxxx Xxxxxx X. Xxxxxx Use of solevnt to modify the implant surface and modify drug release profile [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**]
Xxxx, Xxxxx X. Xxxxxxx and Xxxxx Xxxxxxxxx; Case No. 2008-52399 (the “‘Lawsuit”).
Xxxx, Xxxxx X. Xxxxx Chairman of the Board of Directors President and Chief Executive Officer Neither the Securities and Exchange Commission nor any state securities regulatory agency has approved or disapproved of the merger, passed upon the merits of the merger agreement or the merger or determined if the accompanying proxy statement is accurate or complete. Any representation to the contrary is a criminal offense. The accompanying proxy statement is dated January 14, 2022 and, together with the enclosed form of proxy, is first being mailed to CorePoint stockholders on or about January 18, 2022. CorePoint Lodging Inc. 000 X. Xxxx Xxxxxxxxx Freeway, Suite 1650 Irving, Texas 75062 NOTICE OF SPECIAL MEETING OF STOCKHOLDERS DATE & TIME March 1, 2022 at 9:00 a.m., Central Time VIRTUAL LOCATION xxx.xxxxxxxxxxxxxxxxxxxxxxxxx.xxx/XXXX0000XX ITEMS OF BUSINESS • To consider and vote on a proposal to approve the merger of CorePoint Lodging Inc. (“CorePoint”) with and into Cavalier MergerSub LP (“Merger Sub”) and the other transactions contemplated by the Agreement and Plan of Merger, dated as of November 6, 2021 (as it may be amended from time to time, the “merger agreement”), by and among CorePoint, Cavalier Acquisition Owner LP (as assignee of Cavalier Acquisition JV LP) (“Cavalier”), and Merger Sub (as assignee of Cavalier Acquisition Owner LP) (the “merger proposal”); a copy of the merger agreement is attached to the accompanying proxy statement as Annex A; • To consider and vote on a proposal to approve, on a non-binding, advisory basis, certain compensation that will or may be paid by CorePoint to its named executive officers that is based on or otherwise relates to the merger (the “named executive officer merger-related compensation proposal”); and • To consider and vote on a proposal to approve an adjournment of the special meeting of CorePoint stockholders (the “special meeting”) to a later date or dates, if necessary or appropriate, for the purpose of soliciting additional votes for the approval of the merger proposal if there are insufficient votes to approve the merger proposal at the time of the special meeting or to ensure that any supplement or amendment to the accompanying proxy statement is timely provided to CorePoint stockholders (the “adjournment proposal”). RECORD DATE Only CorePoint common stockholders of record at the close of business on January 14, 2022 (the “record date”), are entitled to notice of, and to vote at, the special meeting and at any adjournm...
Xxxx, Xxxxx X. XXXXXXXX District Engineer
Xxxx, Xxxxx X. Xxxxx) is a close friend of AB.
Xxxx, Xxxxx X. Xxxxxxx, Linpro Maryland Admin Partners Limited Partnership and the Irrevocable Trust of Xxx X. Xxxxxxx (each of which were original limited partners of the Partnership), have assigned and transferred all of, and Xxxx Xxxxxxx has assigned and transferred a portion of, their right, title and interest in and to the Partnership to Linpro Harmans Land Associates Limited Partnership, a Delaware limited partnership ("Linpro"), such interest to be continued as a general partner's interest in the Partnership; and
Xxxx, Xxxxx X. Oimstead Xxxxxx X. Iff Sorb Management Corporation X.X. Xxxx Company Unlimited Unlimited 12.010% of all Indebtedness or $129,000.00, whichever is less Unlimited Unlimited
Xxxx, Xxxxx X. Xxxxxxx -------------- ---------------- Dated: 3/8/99 Dated: 3/8/99 /s/ Xxxxx X. Xxxxxxxx /s/ Xxxxx X. Xxxx
Xxxx, Xxxxx X. Xxxxxxx Xxxxx X. Xxxxxx Xxxx Xxxxxxxxxxx Xxxxx X. Xxxxxxxx Xxx X. Xxxxxx Xxxx X. Xxxxxx SCHEDULE 1 LISTING OF SHARES
Xxxx, Xxxxx X. Xxxxxxxx; The Nassau Group, Inc., SEP FBO Xxxxxx X. Xxxxxx; Xxxxxxx Xxxxxxxxxxx; and Xxxxxxx X. Xxxxx (together, the "Investors"). The Company and the Investors have entered into Subscription Agreements dated as of December 28, 1998, pursuant to which, among other things, the Company sold to the Investors in the aggregate principal amount of 3,055,556 shares of Common Stock, par value $.01 per share (the "Common Stock") for $550,000. In consideration of the foregoing and of the covenants and obligations set forth below, the parties agree as follows:
